WPRIM Management System> DCMS> Chinese Journal of Epidemiology> 2020> 41

Volume: 41

1. New progress in epidemiological research Page:1—5
2. Conducting systematic researches on influencing factors for healthy ageing and promoting scientific implementation of health promotion program for the elderly Page:9—12
3. Association of sleep with anxiety in the elderly aged 60 years and older in China Page:13—19
4. Influencing factors for depressive symptoms in the elderly aged 65 years and older in 8 longevity areas in China Page:20—24
5. Current status of body mass index and related influencing factors in the elderly aged 65 years and older in 8 longevity areas in China Page:25—30
6. Influence of visual impairment on mortality in the elderly aged 65 years and older in 8 longevity areas in China Page:31—35
7. Effects of estimated glomerular filtration rate on all-cause mortality in the elderly aged 65 years and older in 8 longevity areas in China Page:36—41
8. Prediction of 6-year incidence risk of chronic kidney disease in the elderly aged 65 years and older in 8 longevity areas in China Page:42—47
9. Frequency of bowel movements and risk of Parkinson’s disease: a prospective cohort study in adults in China Page:48—54
10. Sugar-sweetened beverages consumption in midlife and risk of late-life cognitive impairment in Chinese adults Page:55—61
11. A comparative study on diagnostic cut points of dyslipidemia in children and adolescents in China Page:62—67
12. Awareness, treatment and control of hypertension in 640 000 adults in eastern China Page:68—73
13. Exposure to famine in fetus and infant period and risk for hypertension in adulthood Page:74—78
14. Status of child health services in less developed areas in Sichuan province, 2014-2018 Page:79—84
15. Assessment of data quality of intervention in population at high risk for HIV/AIDS in China, 2014-2018 Page:85—89
16. Epidemiological characteristics of amoebic dysentery in China, 2015-2018 Page:90—95
17. HIV infection rate in people aged 50 years and older in China: a Meta-analysis Page:96—102
18. Meta-analysis on effectiveness of live attenuated influenza vaccine against seasonal influenza in children Page:103—110
19. A sequential conditional mean model for assessing total effects of exposure in longitudinal data Page:111—114
20. A bibliometric analysis on cohort study of liver cancer in China Page:115—119
21. A review of combined immunization: current research situation and its promising future Page:120—126
22. HIV/AIDS related frailty syndrome in the elderly and related research progress Page:127—130
23. An update on the epidemiological characteristics of novel coronavirus pneumonia(COVID-19) Page:139—144
24. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China Page:145—151
25. Recommendation on the modernization of disease control and prevention Page:453—460
26. Study on assessing early epidemiological parameters of coronavirus disease epidemic in China Page:461—465
27. Dynamic basic reproduction number based evaluation for current prevention and control of COVID-19 outbreak in China Page:466—469
28. Fitting and forecasting the trend of COVID-19 by SEIR+ CAQ dynamic model Page:470—475
29. Estimating the basic reproduction number of COVID-19 in Wuhan, China Page:476—479
30. Prediction modeling with data fusion and prevention strategy analysis for the COVID-19 outbreak Page:480—484
31. Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin Page:489—493
32. Epidemiological analysis on a family cluster of COVID-19 Page:506—509
33. Potential false-positive rate among the 'asymptomatic infected individuals’ in close contacts of COVID-19 patients Page:485—488
34. Advances on presymptomatic or asymptomatic carrier transmission of COVID-19 Page:485—488
35. Comparison of two epidemic patterns of COVID-19 and evaluation of prevention and control effectiveness: an analysis based on Guangzhou and Wenzhou Page:E035—E035
36. Suggestions on reforming and improving the prevention and treatment system for major epidemic diseases in China Page:E054—E054
37. Challenges to prevent and control the outbreak of Novel Coronavirus Pneumonia (COVID-19) Page:E029—E029
38. Thoughts of the COVID-19 outbreak phases changed from emergency response to combination of emergency response and regular prevention and control Page:E045—E045
39. Asymptomatic and pre-symptomatic cases of COVID-19 contribution to spreading the epidemic and need for targeted control strategies Page:E036—E036
40. Discussion on early warning, prevention and control of emerging infectious diseases from a macroscopic perspective based on big data and effective distance model: enlightenment of COVID-19 epidemic data in China Page:E052—E052
41. Clinical outcomes of COVID-19 cases and influencing factors in Guangdong province Page:E057—E057
42. Epidemiological analysis on 1 052 cases of COVID-19 in epidemic clusters Page:E027—E027
43. The preliminary analysis on the characteristics of the cluster for the Corona Virus Disease Page:623—628
44. Risk assessment and early warning of imported COVID-19 in 21 cities, Guangdong province Page:658—662
45. Epidemiological investigation of a family clustering of COVID-19 Page:629—633
46. Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou Page:634—637
47. Epidemiological investigation on a cluster epidemic of COVID-19 in a collective workplace in Tianjin Page:649—653
48. Epidemiological characteristics of confirmed COVID-19 cases in Tianjin Page:638—642
49. Advances on the Asymptomatic Infection of COVID-19 Page:E043—E043
50. COVID-19 Pandemic: global epidemiological trends and China’s subsequent preparedness and responses Page:643—648
51. Interim guidelines for prevention and control of COVID-19 for oversea returnees. Page:1197—1198
52. Interim guidelines for prevention and control of COVID-19 for students back to school. Page:1195—1196
53. Recommendation on the modernization of disease control and prevention. Page:453—460
54. Guideline for epidemiological investigation of coronavirus disease 2019 (T/BPMA 0003-2020). Page:1184—1191
55. Guidelines for personal protection against coronavirus disease 2019 for deseases control person (T/BPMA 0002-2020). Page:1180—1183
56. Technical requirements for preventive disinfection against coronavirus disease 2019 (T/BPMA 0001-2020). Page:1175—1179
57. Expert consensus on immunoprophylaxis of pneumococcal disease (2020 version). Page:1945—1979
58. General principles of description for pathogenic microorganism collection (T/CPMA 011-2020). Page:1791—1797
59. Estimating the basic reproduction number of COVID-19 in Wuhan, China Page:476—479
60. Urgent research agenda for the novel coronavirus epidemic: transmission and non-pharmaceutical mitigation strategies. Page:135—138
61. An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19). Page:139—144
62. Cluster Investigation Technical Guideline for the 2019 Novel Coronavirus Pneumonia (COVID- 19), China (1st Trial Version). Page:293—295
63. Good health management practice for chronic diseases (T/CHAA 007-2019). Page:6—8
64. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Page:145—151
65. Cluster investigation Technical Guidelines for the 2019 Novel Coronavirus Pneumonia (COVID-19), China (1st Trial Version). Page:293—295
66. Consideration on the strategies during epidemic stage changing from emergency response to continuous prevention and control. Page:297—300
67. Technical services specification for vision health management for primary and middle school students (T/CHAA 008-2019). Page:152—161
68. Rapid investigation plan of clinical courses and key diagnosis and treatment equipment requirements for the patients of the 2019 Novel Coronavirus Pneumonia (COVID-19). Page:296—296